As a nice bonus, they also suppress appetite, making them effective for weight loss
Still, the analysts predicted that Ozempic, Wegovy, and Rybelsus (semaglutide) maker Novo Nordisk and Eli Lilly, which developed Zepbound and Mounjaro (tirzepatide), will maintain two-thirds of the market by 2031 due to their first-mover advantages. Other competitors are expected to take a combined $70 billion of the GLP-1 market, the study read
Originally derived from a naturally occurring body protection compound found in the stomach, BPC-157 has gained attention for its regenerative and restorative benefits in muscles, joints, and soft tissue
Hyperhidrosis can be caused by diabetic neuropathy
This leads to systemic inflammation and metabolic responses
Such methods include tissue engineering